D-0366-2024 Class II Ongoing
FDA drug recall D-0366-2024 was initiated by Eugia US LLC on Feb 20, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 10,080 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 13, 2024
- Initiation Date
- Feb 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,080 vials
Product description
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Reason for recall
Failed Dissolution Specifications
Distribution pattern
OH, TN, LA, MS
Code information
Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0366-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026